Open AccessClinical And Cost Efficacy Of Immunotherapy As A First Line Of Treatment Of Nonsquamous Metastatic Non-Small-Cell Lung Cancer
Author(s) -
T. Веков,
N Veleva,
Valentina Belcheva,
Jivko Kolev
Publication year - 2020
Publication title -
godišnik po bolnična farmaciâ
Language(s) - English
Resource type - Journals
eISSN - 2603-3852
pISSN - 2367-8763
DOI - 10.14748/ahp.v6i1.7156
Subject(s) - medicine , pembrolizumab , atezolizumab , pemetrexed , carboplatin , oncology , clinical trial , nivolumab , lung cancer , immunotherapy , chemotherapy , cancer , cisplatin